ESR1 and breast cancer: In addition to the prognostic value of CD8+ density in the tumor aspect, we report an independent prognostic contribution of the ID indicator of CD8+ density in ER+HER2– BC tumors (Table 4, models 3 and 5), highlighting the value of the density profiles across the tumor-stroma IZ.